Walgreens Boots Alliance, Inc. (WBA)

WBA Income Statement

Revenue, expenses, and profitability analysis

WBA Quarterly Income Statement (USD)

Quarterly Report	TTM	05/31/2025	02/28/2025	11/30/2024	08/31/2024	05/31/2024	02/29/2024	11/30/2023	08/31/2023
Revenue	154.580B	38.986B	38.588B	39.459B	37.547B	36.351B	37.052B	36.707B	35.422B
Cost of Goods Sold	128.108B	32.480B	31.654B	32.680B	31.294B	29.892B	30.012B	29.937B	28.947B
Gross Profit	26.472B	6.506B	6.934B	6.779B	6.253B	6.459B	7.040B	6.770B	6.475B
Gross Profit Margin	16.7%	16.7%	18.0%	17.2%	16.7%	17.8%	19.0%	18.4%	18.3%
Total Operating Expenses	33.208B	6.453B	12.501B	7.024B	7.230B	6.348B	20.211B	6.809B	6.926B
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling, General & Administrative	29.347B	6.493B	8.891B	7.015B	6.948B	6.393B	7.921B	6.851B	6.990B
Operating Income (EBIT)	-3.116B	53.000M	-1.956B	-236.000M	-977.000M	111.000M	-13.171B	-39.000M	-451.000M
Operating Margin	0.1%	0.1%	-5.1%	-0.6%	-2.6%	0.3%	-35.5%	-0.1%	-1.3%
Income Before Tax (EBT)	-5.853B	-70.000M	-4.246B	-539.000M	-998.000M	250.000M	-13.104B	-352.000M	-58.000M
Interest Income	—	—	—	—	—	—	—	—	—
Interest Expense	508.000M	126.000M	129.000M	122.000M	131.000M	113.000M	138.000M	99.000M	155.000M
Other Income/Expense	-2.737B	-123.000M	-2.290B	-303.000M	-21.000M	139.000M	67.000M	-313.000M	393.000M
Net Income	-6.298B	-175.000M	-2.853B	-265.000M	-3.005B	344.000M	-5.908B	-67.000M	-180.000M
Income Tax Expense	2.062B	126.000M	-212.000M	66.000M	2.082B	20.000M	-782.000M	-74.000M	151.000M
Net Profit Margin	-0.4%	-0.4%	-7.4%	-0.7%	-8.0%	0.9%	-15.9%	-0.2%	-0.5%
EBITDA	-2.919B	624.000M	-3.507B	209.000M	-245.000M	971.000M	-12.362B	357.000M	385.000M
EBITDA Margin	1.6%	1.6%	-9.1%	0.5%	-0.7%	2.7%	-33.4%	1.0%	1.1%
Depreciation & Amortization	2.431B	573.000M	611.000M	625.000M	622.000M	607.000M	614.000M	616.000M	605.000M
EPS Basic	-7.29	-0.20	-3.30	-0.31	-3.48	0.40	-6.85	-0.08	-0.21
EPS Diluted	-7.29	-0.20	-3.30	-0.31	-3.48	0.40	-6.85	-0.08	-0.21
Shares Outstanding	864.900M	864.900M	864.100M	863.800M	863.700M	863.100M	862.500M	863.000M	864.300M
Diluted Shares Outstanding	864.900M	864.900M	864.100M	863.800M	863.700M	864.300M	862.500M	863.000M	864.300M

WBA Annual Income Statement (USD)

Annual Report	08/31/2024	08/31/2023	08/31/2022	08/31/2021	08/31/2020	08/31/2019	08/31/2018	08/31/2017
Revenue	147.658B	139.081B	132.703B	132.509B	121.982B	120.074B	131.537B	118.214B
Cost of Goods Sold	121.134B	112.009B	104.437B	104.442B	95.905B	91.915B	100.745B	89.052B
Gross Profit	26.524B	27.072B	28.266B	28.067B	26.077B	28.159B	30.792B	29.162B
Gross Profit Margin	18.0%	19.5%	21.3%	21.2%	21.4%	23.5%	23.4%	24.7%
Total Operating Expenses	40.600B	33.954B	26.879B	25.725B	25.095B	23.393B	24.503B	23.678B
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling, General & Administrative	28.113B	34.205B	27.295B	24.586B	25.436B	23.557B	24.694B	23.813B
Operating Income (EBIT)	-14.076B	-6.882B	1.387B	2.342B	982.000M	4.766B	6.289B	5.484B
Operating Margin	-9.5%	-4.9%	1.0%	1.8%	0.8%	4.0%	4.8%	4.6%
Income Before Tax (EBT)	-14.202B	-5.386B	4.036B	2.622B	477.000M	4.367B	6.029B	4.861B
Interest Income	—	—	—	—	—	—	—	—
Interest Expense	482.000M	580.000M	400.000M	905.000M	613.000M	650.000M	616.000M	693.000M
Other Income/Expense	-126.000M	1.463B	2.649B	280.000M	-505.000M	-399.000M	-260.000M	-623.000M
Net Income	-8.636B	-3.080B	4.337B	2.542B	456.000M	3.982B	5.024B	4.078B
Income Tax Expense	1.246B	-1.858B	-30.000M	667.000M	339.000M	577.000M	998.000M	760.000M
Net Profit Margin	-5.8%	-2.2%	3.3%	1.9%	0.4%	3.3%	3.8%	3.4%
EBITDA	-11.278B	-2.582B	5.262B	6.242B	5.168B	7.014B	7.670B	6.953B
EBITDA Margin	-7.6%	-1.9%	4.0%	4.7%	4.2%	5.8%	5.8%	5.9%
Depreciation & Amortization	2.459B	2.257B	1.990B	1.973B	1.927B	2.038B	1.770B	1.654B
EPS Basic	-10.01	-3.57	5.02	2.31	0.52	4.14	5.07	3.80
EPS Diluted	-10.01	-3.57	5.01	2.30	0.52	4.13	5.05	3.78
Shares Outstanding	863.100M	863.200M	864.400M	864.800M	879.400M	921.500M	991.000M	1.073B
Diluted Shares Outstanding	863.100M	863.200M	865.900M	866.400M	880.300M	923.500M	995.000M	1.079B

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance, Inc., established in 1901 and based in Deerfield, Illinois, operates as a leading global retailer focused on pharmacy, health, and beauty products. Its business activities are organized into two primary divisions: the United States and International. In the United States, the company dispenses prescription drugs and offers a diverse selection of retail goods. This includes items for health, wellness, beauty, and personal care, alongside general merchandise and consumable products, all available through its extensive network of retail drugstores. The U.S. segment also provides specialized central pharmacy services and mail delivery options for prescriptions. As of August 31, 2021, this division managed 8,965 retail outlets under the Walgreens and Duane Reade banners, complemented by five specialty pharmacies. The International segment focuses on the sale of prescription medications, health and wellness items, beauty products, personal care essentials, and other consumer goods. These are sold through its pharmacy-centric health and beauty retail locations, optical practices, its online platform boots.com, and an integrated mobile application. Additionally, this segment engages in pharmaceutical wholesale and distribution operations within Germany. By August 31, 2021, the international portfolio included 4,031 retail stores operating under brands such as Boots, Benavides, and Ahumada, located across countries including the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. It also oversaw 548 optical practices, with 160 of these operating as franchises.

Deerfield, IL

193,000 employees

www.walgreensbootsalliance.com

Healthcare / Medical - Pharmaceuticals

Sector: Healthcare
Industry: Medical - Pharmaceuticals
CEO: Timothy C. Wentworth

View full financials